A New York-based multi-state operator has received conditional approval to list its shares on the Toronto Stock Exchange (TSX) as Canadian prices for wholesale flower continue to climb.
Outside North America, Germany is facing another setback on the long road to cannabis legalization, while Japan has legalized medical cannabis, but toughened repercussions for recreational users.
Read on to learn what else happened in the cannabis space this week.
Curaleaf receives conditional approval for TSX listing
Two months after applying to list on the TSX, cannabis producer Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) has received conditional approval to list its subordinate voting shares on the exchange.
The company issued the news on Thursday (December 7) via a press release. “We are now one step closer to accessing an even broader set of global institutional investors than we currently have, alongside the capital and…
